[Test use of dihydrostreptomycin ascorbinate in pulmonary tuberculosis].
D000328:Adult; D001205:Ascorbic Acid; D002986:Clinical Trials as Topic; D004096:Dihydrostreptomycin Sulfate / Q000627:therapeutic use*; D003875:Drug Eruptions; D004802:Eosinophilia / Q000139:chemically induced; D005260:Female; D006261:Headache / Q000139:chemically induced; D006801:Humans; D008297:Male; D008875:Middle Aged; D013307:Streptomycin / Q000009:adverse effects / Q000627:therapeutic use*; D013431:Sulfates; D014012:Tinnitus / Q000139:chemically induced; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*; D014717:Vertigo / Q000139:chemically induced
D013431:Sulfates; D001205:Ascorbic Acid; D004096:Dihydrostreptomycin Sulfate; D013307:Streptomycin
Opyt primeneniia digidrostreptomitsin-askorbinata pri tuberkuleze legkikh.